← Evidence map

ReviewPloS one2022

Information about confirmatory studies required for new drugs conditionally approved by Health Canada: A cross-sectional study.

Joel LexchinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36264963